YORK, Pa., Nov. 22, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its CEO, Alan Shortall will be presenting at the 25th Annual Piper Jaffray Healthcare Conference in New York City at 2:30 p.m. ET on Wednesday, December 4, 2013.
The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's extensive portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, intraocular delivery systems and specialized devices. Each of these innovative, differentiated platforms can be customized by Unilife to address specific customer, drug and patient requirements. Unilife's global headquarters and advanced manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.
General: UNIS-G
|
Investor Contacts (US):
|
Analyst Enquiries
|
Investor Contacts (Australia)
|
|
Todd Fromer / Garth Russell
|
Lynn Pieper
|
Jeff Carter
|
|
KCSA Strategic Communications
|
Westwicke Partners
|
Unilife Corporation
|
|
P: + 1 212-896-1215 / 212-896-1250
|
P: + 1 415-202-5678
|
P: + 61 2 8346 6500
|
SOURCE Unilife Corporation
